Next Generation Personalized Neuroblastoma Therapy
Stopped The goals of Part 1 (molecular screening) were met, but lack of therapies to match molecular aberrations made Part 2 (treatment) no longer feasible.
Conditions
Interventions
- PROCEDURE: Biopsy
- GENETIC: Next Generation Sequencing
- PROCEDURE: Tumor Scans
- PROCEDURE: Bone marrow Tests
- OTHER: Physical Exam
- OTHER: Eye Exam
- OTHER: Labs
- OTHER: Pregnancy Test
- BEHAVIORAL: Interviews
- OTHER: ECG
- OTHER: Echocardiogram
- DRUG: Ribociclib
- DRUG: Ceritinib
Sponsor
Yael P Mosse
Collaborators
- [object Object]
- [object Object]